Auto-Injectors Market Size, Application, Region and Growth Forecast 2030
Global Auto-Injectors
Market to Post a CAGR of 17.2% Between 2016 and 2022
The Auto-Injectors
Market is expected to reach USD 6,753.5 Million by 2030 at 14.2% CAGR during
the forecast period 2022-2030.
Auto-injectors fall under an important segment of medical
devices designed to drug dose delivery in a calculated manner. These injectors
are used for delivering life-saving drugs. They are extremely effective in
tackling severe allergic reactions. Auto-injectors are one of the several
inventions focused toward bettering care giving. The continuous advances in
medical technology has led to development of effective auto-injectors. Latest
versions of the device are more user-friendly and cost-efficient. These
injectors are intended for self-administration by patients. They do not require
special training for homecare givers to administer drugs. Such factors make the
devices extremely important and practical.
The advent of auto-injectors has helped in tackling the
challenges faced in self-administration. These injectors are far more superior
than conventional needle-based drug delivery devices. The technology is
quite simple, as spring-loaded system is used in for functionality. Most
auto-injectors that are currently available have plastic body, which help in
deterring unnecessary contamination.
Rising incidences of allergic diseases associated with anaphylaxis and
other allergies globally is expected to influence the global auto-injectors
market.
Global Auto-Injectors Market: Competitive Landscape
UNILIFE CORPORATION, Enbrel, Owen Mumford Ltd., Amedra
Pharmaceuticals LLC, Scandinavian Health Ltd., and kaleo, Inc. are among
the global Auto-Injectors
Market Players.
Global Auto-Injectors
Market: Segmental Overview
The segmental analysis of the global auto-injectors market
has been conducted on the basis of product type, application, and suppliers.
·
Based on product type, the market has
been segmented into reusable, disposable and others.
·
Based on application, the market has been
segmented into rheumatoid arthritis, anaphylaxis, multiple sclerosis, allergies
and others.
·
Based on supplier, the market has been
segmented into retailers, pharmacy, online retailers and others.
Global Auto-Injectors
Market: Regional Segmentation
Key regions mentioned in MRFR’s report include South
America, North America, Europe, Asia Pacific (APAC) and the Middle East &
Africa (MEA). In terms of revenue, North America holds the top spot in the
global auto-injectors market. In addition, the auto-injectors market in North
America is projected to reach the size of USD 0.9 Bn towards the end of
assessment period. Faster uptake of advanced technologies and presence of a
robust healthcare systems in the U.S. is supporting the market growth in the
region. North America is expected to remain a highly attractive market for
auto-injectors during the forecast period. Europe holds the second spot in the
global auto-injectors market in terms of revenue. Factors such as high
healthcare expenditure and strong government support are propelling the market
in Europe. Meanwhile, the APAC auto-injectors market is expected to exhibit a register
the highest CAGR during the forecast period.
Industry News
- Lupin Limited, a
multi-national pharmaceutical company is reportedly positioning itself to
enter the sterile injectable products segment in distinct class of
ready-to-use platform. The company has significant capacity in both the
supply chain and operation. The company recently commissioned an
injectables facility at Nagpur. The company has 9 R&D and 18
manufacturing units worldwide. Additionally, the company has a vast
product portfolio, which includes capsules, injectable, dry
powder inhalers (DPIs), tablets, metered dose inhalers (MDIs) and
sterile and non-sterile liquids.
- US-based pharmaceutical
company ARS Pharmaceuticals, Inc., which specializes in assisting at-risk
patients recently announced the result from its EPI-04 clinical research
analysis, which evaluates the pharmacokinetics of epinephrine after
administration of ARS-1. The company is renowned for its offerings in
severe allergic reactions.
Related Report-
·
https://www.xaphyr.com/blogs/190681/Breast-Cancer-Market-Trends-is-Set-to-Experience-a-Revolutionary
About US:
Market Research
Future (MRFR) enable customers to unravel the complexity of various industries
through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw
Research Reports (3R), Continuous-Feed Research (CFR), and Market Research
& Consulting Services.
Contact us:
Market Research
Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th
Floor, New York,
New York 10013
Comments
Post a Comment